000			01512nam a22003257a 4500
001			20241002100053.0
003			20241002100053.0
005			20241002100655.0
008			241002b |||||||| |||| 00| 0 eng d
010			_a2018960201
020			_a978-3-030-03501-3
020			_a978-3-030-03502-0
022			_a0927-3042
022			_a2509-8497
040			_cddc
041			_aEnglish
082			_a616.994 MEY
100			_qCraig Meyers
245			_aHIV/AIDS-Associated Viral Oncogenesis
250			_a Second Edition
260			_aPenn State University Hershey, PA, USA | _bSpringer Nature Switzerland AG | _c 2019
490			_ahttps://doi.org/10.1007/978-3-030-03502-0 _vCancer Treatment and Research
520			_aAIDS is a major worldwide health care crisis. One of the most important aspects of the disease is the loss of protective immune function in the infected host which leads to increased prevalence of opportunistic infections and cancers. Of particular note are viral-associated cancers. Aids-Associated Viral Oncogenesis will specifically address viral-induced human cancers. Topics will cover the viral associated cancers observed in the AIDS population, specific treatment required in this special population, and molecular biology of the causative viral agents.
600			_xOncology.
600			_xInfectious Diseases.
600			_xImmunology.
600			_xVirology.
856			_uhttps://doi.org/10.1007/978-3-030-03502-0
942			_2ddc _cEB _n0
999			_c29009 _d29009